Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0153129002
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Marketed | 02511355 | NOVARTIS PHARMACEUTICALS CANADA INC | KESIMPTA | Human | Yes | Prescription | 1 | OFATUMUMAB | 20 MG / 0.4 ML |
Marketed | 02511355 | NOVARTIS PHARMACEUTICALS CANADA INC | KESIMPTA | Human | Yes | Schedule D | 1 | OFATUMUMAB | 20 MG / 0.4 ML |
Approved | 02511363 | NOVARTIS PHARMACEUTICALS CANADA INC | KESIMPTA | Human | Yes | Schedule D | 1 | OFATUMUMAB | 20 MG / 0.4 ML |
Approved | 02511363 | NOVARTIS PHARMACEUTICALS CANADA INC | KESIMPTA | Human | Yes | Prescription | 1 | OFATUMUMAB | 20 MG / 0.4 ML |
Application information
Related information
Contact us
Version 4.0.3